Antileishmanial activity of benzocycloalkyl azole oximino ethers: The conformationally constraint analogues of oxiconazole

Acta Tropica

Volumn 117, Issue 2, 2011, Pages 157-160

  Verma, Aditya ^a   Srivastava, Saumya ^a   Sane, Shraddha A ^a   Marrapu, Vijay K ^a   Srinivas, Nagarapu ^a   Yadav, Manisha ^a   Bhandari, Kalpana ^a   Gupta, Suman ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antileishmanial activity; Benzocycloalkyl azole oximino ethers; Luciferase assay; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; ARYLOXYARYLALKYL AZOLE DERIVATIVE; BENZOCYCLOALKYL AZOLE OXIMINO ETHER DERIVATIVE; ECONAZOLE; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; MILTEFOSINE; OXICONAZOLE; PENTAMIDINE; POSACONAZOLE; PYRROLE DERIVATIVE; STIBOGLUCONATE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

BIOASSAY; ENZYME ACTIVITY; INHIBITION; NUMERICAL MODEL; PARASITE; TESTING METHOD;

AMASTIGOTE; ANTIBIOTIC RESISTANCE; ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; HAMSTER; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIASIS; MORTALITY; NONHUMAN; PROMASTIGOTE; SKIN LEISHMANIASIS; TERATOGENICITY; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIPARASITIC AGENTS; CRICETINAE; DISEASE MODELS, ANIMAL; ETHERS; IMIDAZOLES; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LETHAL DOSE 50;

CRICETINAE; LEISHMANIA DONOVANI;

EID: 78650974605     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2010.10.011     Document Type: Article

References (26)

1. Al-Abdely H.M., Graybill J.R., Loebenberg D., Melby P.C. Efficacy of the triazole SCH 56592 against L. amazonensis and L. donovani in experimental murine cutaneous and visceral leishmaniases. Antimicrobial Agents & Chemotherapy 1999, 43:2910-2914.
2. Ashutosh, Gupta S., Ramesh, Sundar S., Goyal N. Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening. Antimicrobial Agents & Chemotherapy 2005, 49:3776-3783.
3. Beach D.H., Goad L.J., Holz G.G. Effects of antimycotic azoles on growth and sterol biosynthesis of leishmania promastigotes. Molecular & Biochemical Parasitology 1998, 31:149-162.
4. Berman J.D. Activity of imidazoles against Leishmania tropica in human macrophage cultures. American Journal of Tropical Medicine and Hygiene 1981, 30:566-569.
5. Bern C., Adler-Moore J., Berenguer J., Boelaert M., Boer M.den., Davidson N.R., Figueras C., Gradoni L., Kafetzis A.D., Ritmeijer K., Rosenthal E., Royce C., Russo R., Sundar S., Alvar J. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clinical Infectious Diseases 2006, 43:917-924.
6. Bhandari, K., Srinivas, N., Palne, S., Nishi, Gupta, S., 2008. Novel substituted benzocycloalkyl azole derivatives as antileishmanial agents. Ind. Pat. 610 DEL.
7. Bhandari K., Srinivas N., Keshava b G.B.S., Shukla P.K. Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials. European Journal of Medicinal Chemistry 2009, 44:437-447.
8. Bhandari K., Srinivas N., Marrapu V.K., Verma A., Srivastava S., Gupta S. Synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents. Bioorganic & Medicinal Chemistry Letters 2010, 20:291-293.
9. Bhatnagar S., Guru P.Y., Katiyar J.C., Srivastava R., Mukherjee A., Akhtar M.S., Seth M., Bhaduri A.P. Exploration of antileishmanial activity in heterocycles; results of their in vivo & in vitro bioevaluations. Indian Journal of Medical Research 1989, 89:439-444.
10. Bryceson A. A policy for leishmaniasis with respect to the prevention and control of drug resistance. Tropical Medicine & International Health 2001, 6:928-934.
11. Croft S., Neal R., Pendergast W., Chan J.H. The activity of alkyl phosphocholines and related derivates against Leishmania donovani. Biochemical Pharmacology 1987, 36:2633-2636.
12. Fuertes A.M., Nguewa A.P., Castilla J., Carlos A., Pérez J.M. Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives. Current Medicinal Chemistry 2008, 15:433-439.
13. Gupta S., Tiwari S., Bhaduri A.P., Jain G.K. Anilino-(2-bromophenyl) acetonitrile: a promising orally effective antileishmanial agent. Acta Tropica 2002, 84:165-173.
14. Gupta L., Talwar A., Nishi, Palne S., Gupta S., Chauhan P.M.S. Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents. Bioorganic & Medicinal Chemistry Letters 2007, 17:4075-4079.
15. Hart D.T., Lauwers W.J., Willemsens G., Bossche H.V., Opperdoes F.R. Perturbation of sterol biosynthesis by itraconazole and ketoconazole in L. mexicana infected macrophages. Molecular & Biochemical Parasitology 1989, 33:123-134.
16. Huber W., Koella J.C. A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites. Acta Tropica 1993, 55:257-261.
17. Janvier F., Morillon M., Olliaro P. Visceral leishmaniasis: clinical sensitivity and resistance to various therapeutic agents. Medecine Tropicale (Mars) 2008, 68:89-101.
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65:55-63.
19. Porwal S., Chauhan S.S., Chauhan P.M.S., Shakya N., Verma A., Gupta S. Discovery of novel antileishmanial agents in an attempt to synthesize pentamidine-aplysinopsin hybrid molecule. Journal of Medicinal Chemistry 2009, 52(19):5793-5802.
20. Srinivas N., Palne S., Nishi, Gupta S., Bhandari K. Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents. Bioorganic & Medicinal Chemistry Letters 2009, 19:324-327.
21. Sundar S. Drug resistance in Indian visceral leishmaniasis. Tropical Medicine & International Health 2001, 6:849-854.
22. Sundar S., Chatterjee M. Visceral leishmaniasis - current therapeutic modalities. Indian Journal of Medical Research 2006, 123:345-352.
23. Urbina J.A. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology 1997, 114(S91):9.
24. Veeken H., Ritmeijer K. Leishmaniasis: progress in diagnosis, treatment and prevention. Nederlands tijdschrift voor geneeskunde 2006, 150:2686-2688.
25. Wali J.P., Aggarwal P., Gupta U., Saluja S., Singh S. Ketoconazole in treatment of visceral leishmaniasis. The Lancet 1990, 336(8718):810-811.
26. Weinrauch L., Livishin R., El-On J. Ketoconazole in cutaneous leishmaniasis. British Journal of Dermatology 1987, 117:666-667.